Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001789769-26-000030
Filing Date
2026-04-24
Accepted
2026-04-24 16:20:34
Documents
14
Period of Report
2026-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A til-20260424.htm   iXBRL DEF 14A 347766
3 GRAPHIC til-20260424_g1.jpg GRAPHIC 12773
4 GRAPHIC til-20260424_g2.jpg GRAPHIC 217402
5 GRAPHIC til-20260424_g3.jpg GRAPHIC 206705
  Complete submission text file 0001789769-26-000030.txt   1756153

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20260424.xsd EX-101.SCH 917
17 EXTRACTED XBRL INSTANCE DOCUMENT til-20260424_htm.xml XML 4288
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40215 | Film No.: 26894372
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)